The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

被引:34
|
作者
Mos, J
VanHest, A
VanDrimmelen, M
Herremans, AHJ
Olivier, B
机构
[1] TRAMARKO, NL-1353 AE ALMERE, NETHERLANDS
[2] UNIV UTRECHT, FAC PHARM, DEPT PSYCHOPHARMACOL, NL-3508 TB UTRECHT, NETHERLANDS
关键词
drug discrimination; flesinoxan; DU125530; 5-HT1A receptor; (pigeon);
D O I
10.1016/S0014-2999(97)00131-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Twelve homing pigeons were trained to discriminate the 5-HT1A receptor agonist flesinoxan (0.25 mg/kg p.o.) from its vehicle in a fixed ratio (FR) 30 two-key operant drug discrimination procedure. Tests for generalization and antagonism showed that compounds with agonistic action at the 5-HT1A receptor, such as 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin) buspirone and ipsapirone all substituted for the flesinoxan cue. Compounds with mixed agonistic action at the 5-HT1A/1B receptor fully (eltoprazine) or partially (RU24969 (5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl-1H-indole)) substituted for flesinoxan. TFMPP (1-(3-trifluoromethyl phenyl)piperazine) and mCPP(1-(3-chlorophenyl)piperazine), both acting at the 5-HT1B/2C receptor, did not substitute for flesinoxan, neither did the selective 5-HT re-uptake inhibitor fluvoxamine. The results of the antagonism tests showed that the 5-HT1A receptor antagonists NAN-190 (1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butly]piperazine), WAY 100635 ((N-[2-[4-(2-methaxyphenyl)- 1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclo-hexane-carboxamide) and the newly developed DU125530 (2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)- 1-piperazinyl]butyl]-1,2-benzisothiazol-3(2H)-one-1,1-dioxide) fully (more than 80%) blocked the flesinoxan cue without having substantial effects when given alone. WAY100135 (N-tert-butyl-3-(4-(2-methoxyphenyl)piperazine-1-yl)-2-phenylpropanamide), (+/-)-pindolol and (S)-UH-301 ((S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin all partially antagonized the flesinoxan cue. However, both WAY100135 as well as (+/-)-pindolol also partially substituted for flesinoxan in generalization tests. NAN190, (S)-UH-301, WAY100635 and DU125530 were without any activity in the generalization test at the doses tested. The putative 5-HT1A receptor antagonist S15535 (4-benzodioxan-5-yl) 1-(indan-2-yl)piperazine) was identified as a full agonist in the present procedure. Taken together these results suggest that the flesinoxan cue in pigeons is mediated by the 5-HT1A receptor and that DU125530 acts as a full antagonist on the 5-HT1A receptor.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [31] EFFECTS OF THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST SDZ-216,525 IN 2 MODELS OF SOMATODENDRITIC 5-HT1A AUTORECEPTOR FUNCTION
    GURLING, J
    ASHWORTHPREECE, MA
    HARTLEY, JE
    FLETCHER, A
    DOURISH, CT
    ROUTLEDGE, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 : P255 - P255
  • [32] Efficacy of a 5-HT1a receptor agonist in atopic dermatitis
    Kawana, S.
    Kato, Y.
    Omi, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (08) : 835 - 840
  • [33] A NEW PUTATIVE 5-HT1A RECEPTOR ANTAGONIST OF THE 1-ARYLPIPERAZINE CLASS OF LIGANDS
    CHOJNACKAWOJCIK, E
    KLODZINSKA, A
    DRABCZYNSKA, A
    PAWLOWSKI, M
    CHARAKCHIEVAMINOL, S
    CHLON, G
    GORCZYCA, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (7-8) : 587 - 592
  • [34] Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents
    Alfredo, BA
    Ofir, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 508 (1-3) : 155 - 158
  • [35] THE RENAL FUNCTIONAL-RESPONSES TO 5-HT1A RECEPTOR AGONIST, FLESINOXAN, IN ANESTHETIZED, NORMOTENSIVE RAT
    CHAMIENIA, AL
    JOHNS, EJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) : 214 - 218
  • [36] IN-VIVO CHARACTERIZATION OF THE PUTATIVE 5-HT1A RECEPTOR ANTAGONIST SDZ-216,525 USING 2 MODELS OF SOMATODENDRITIC 5-HT1A RECEPTOR FUNCTION
    ROUTLEDGE, C
    HARTLEY, J
    GURLING, J
    ASHWORTHPREECE, M
    BROWN, G
    DOURISH, CT
    NEUROPHARMACOLOGY, 1994, 33 (3-4) : 359 - 366
  • [37] Electrophysiological evidence for rapid 5-HT1A autoreceptor inhibition by vilazodone, a 5-HT1A receptor partial agonist and 5-HT reuptake inhibitor
    Ashby, Charles R., Jr.
    Kehne, John H.
    Bartoszyk, Gerd D.
    Renda, Matthew J.
    Athanasiou, Maria
    Pierz, Kerri A.
    Seyfried, Christoph A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 714 (1-3) : 359 - 365
  • [38] ANTICONFLICT AND DISCRIMINATIVE STIMULUS EFFECTS OF THE 5-HT1A COMPOUNDS WY-47,846 AND WY-48,723 AND THE MIXED 5-HT1A AGONIST 5-HT2 ANTAGONIST WY-50,324 IN PIGEONS
    BARRETT, JE
    ZHANG, L
    DRUG DEVELOPMENT RESEARCH, 1991, 24 (02) : 179 - 188
  • [39] The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats
    Bjorvatn, B
    Fornal, CA
    Martín, FJ
    Metzler, CW
    Jacobs, BL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 356 (2-3) : 167 - 178
  • [40] Development of 5-HT1A receptor antagonists
    Routledge, C
    BEHAVIOURAL BRAIN RESEARCH, 1996, 73 (1-2) : 153 - 156